SynthesisBMC infectious diseases2025
Toxoplasmosis landscape: a systematic review and meta-analysis of seroprevalence in healthy and non-healthy individuals in Sudan (1990-2025).
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessment of Awareness, Knowledge, and Self-Reported Prevalence of Toxoplasmosis in the Tropical Zone of Saudi Arabia: A Cross-Sectional Study.Tropical medicine and infectious disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundHuman toxoplasmosis is a widespread zoonotic infection with significant public health implications, particularly in Sudan, where the disease burden is high. However, the overall prevalence of Toxoplasma gondii infection in the country remains unclear. This systematic review and meta-analysis aimed to estimate the pooled seroprevalence of human toxoplasmosis in Sudan and identify associated risk factors.
methodsA comprehensive search was conducted in English and Arabic databases for studies published before February 28, 2025, following PRISMA guidelines. The meta-analysis included 60 studies with 10,866 participants from different regions of Sudan.
resultsThe pooled seroprevalence of human toxoplasmosis was 36% (95% CI: 31-41%), with significant heterogeneity (I
conclusionToxoplasmosis remains highly endemic in Sudan, with certain groups-including males, hemodialysis patients, women of childbearing age, HIV patients, and workers exposed to animals-at heightened risk. Targeted public health interventions are necessary to reduce the disease burden among high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.